Small Intestinal Adenocarcinoma
What's New
Last Posted: Mar 01, 2023
- Loss of HES-1 Expression Predicts a Poor Prognosis for Small Intestinal Adenocarcinoma Patients.
Kim Jeong Won, et al. Frontiers in oncology 2020 0 1427 - Tumor Microenvironmental Prognostic Risk in Primary Operable Small Intestinal Adenocarcinoma.
Jun Sun-Young, et al. The American journal of surgical pathology 2021 0 (7) 917-929 - Prognostic implication of SOX2 expression in small intestinal adenocarcinoma.
Kim Jeong Won, et al. Virchows Archiv : an international journal of pathology 2020 10 - Clinicopathologic and prognostic associations of KRAS and BRAF mutations in small intestinal adenocarcinoma.
Jun Sun-Young, et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 2 - Molecular alterations of EGFR in small intestinal adenocarcinoma.
Wang Yan, et al. International journal of colorectal disease 2013 10 (10) 1329-35 - Genetics and epigenetics of small bowel adenocarcinoma: the interactions of CIN, MSI, and CIMP.
Warth Arne, et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011 4 (4) 564-70 - Small Intestinal Adenocarcinoma
From NCATS Genetic and Rare Diseases Information Center
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: